Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Clinical research published in Biochemical Pharmacology demonstrates that 5 amino 1mq treatment significantly reduces NNMT activity in adipocytes, leading to increased intracellular NAD+ concentrations
BPC-157 is not FDA-approved for medical treatment
It does not provide medical advice or instructions for human use
While NAD+ precursors (like NMN or NR) aim to increase NAD+ levels directly, 5-Amino-1MQ is studied for its upstream regulatory approachpotentially increasing NAD+ by blocking its consumption rather than adding more precursors
US$ 24.43
US$ 20.78
US$ 26.69
US$ 21.60
US$ 22.46
US$ 25.90
